Why is MiMedx Group, Inc. ?
- OPERATING CASH FLOW(Y) Highest at USD 68.93 MM
- RAW MATERIAL COST(Y) Fallen by -2.36% (YoY)
- CASH AND EQV(HY) Highest at USD 260.95 MM
- Over the past year, while the stock has generated a return of -44.32%, its profits have fallen by -52.5%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 2.32% over the previous quarter.
How much should you buy?
- Overall Portfolio exposure to MiMedx Group, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is MiMedx Group, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 68.93 MM
Fallen by -2.36% (YoY
Highest at USD 260.95 MM
Lowest at -51.84 %
Highest at USD 113.72 MM
Highest at USD 27.48 MM
Highest at 24.16 %
Highest at USD 22.85 MM
Highest at USD 16.75 MM
Highest at USD 0.11
Here's what is working for MiMedx Group, Inc.
Operating Cash Flows (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Sales (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Cash and Cash Equivalents
Debt-Equity Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Depreciation (USD MM)






